Conotoxins Targeting Neuronal Voltage-gated Sodium Channel Subtypes: Potential Analgesics?

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2012 Dec 4

PMID 23202314

Citations 25

Authors

Oliver Knapp

Jeffrey R McArthur

David J Adams

Affiliations

Soon will be listed here.

Abstract

Voltage-gated sodium channels (VGSC) are the primary mediators of electrical signal amplification and propagation in excitable cells. VGSC subtypes are diverse, with different biophysical and pharmacological properties, and varied tissue distribution. Altered VGSC expression and/or increased VGSC activity in sensory neurons is characteristic of inflammatory and neuropathic pain states. Therefore, VGSC modulators could be used in prospective analgesic compounds. VGSCs have specific binding sites for four conotoxin families: μ-, μO-, δ- and ί-conotoxins. Various studies have identified that the binding site of these peptide toxins is restricted to well-defined areas or domains. To date, only the μ- and μO-family exhibit analgesic properties in animal pain models. This review will focus on conotoxins from the μ- and μO-families that act on neuronal VGSCs. Examples of how these conotoxins target various pharmacologically important neuronal ion channels, as well as potential problems with the development of drugs from conotoxins, will be discussed.

Citing Articles

Marine-derived bioactive compounds for neuropathic pain: pharmacology and therapeutic potential.

Mishra S, Mishra Y, Kumar A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39797987 DOI: 10.1007/s00210-024-03667-7.

Artificial Intelligence-Assisted Comparative Analysis of the Overlapping Molecular Pathophysiology of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Wei Z, Iyer M, Zhao B, Deng J, Mitchell C Int J Mol Sci. 2025; 25(24.

PMID: 39769215 PMC: 11678588. DOI: 10.3390/ijms252413450.

Nutraceutical and Medicinal Importance of Marine Molluscs.

Ngandjui Y, Kereeditse T, Kamika I, Madikizela L, Makudali Msagati T Mar Drugs. 2024; 22(5).

PMID: 38786591 PMC: 11123371. DOI: 10.3390/md22050201.

Voltage-Gated Sodium Channel Inhibition by µ-Conotoxins.

McMahon K, Vetter I, Schroeder C Toxins (Basel). 2024; 16(1).

PMID: 38251271 PMC: 10819908. DOI: 10.3390/toxins16010055.

Historical Perspective of the Characterization of Conotoxins Targeting Voltage-Gated Sodium Channels.

Groome J Mar Drugs. 2023; 21(4).

PMID: 37103349 PMC: 10142487. DOI: 10.3390/md21040209.

References

Clark R, Jensen J, Nevin S, Callaghan B, Adams D, Craik D . The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl. 2010; 49(37):6545-8. DOI: 10.1002/anie.201000620. View

Fertleman C, Baker M, Parker K, Moffatt S, Elmslie F, Abrahamsen B . SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron. 2006; 52(5):767-74. DOI: 10.1016/j.neuron.2006.10.006. View

McArthur J, Singh G, OMara M, McMaster D, Ostroumov V, Tieleman D . Orientation of μ-conotoxin PIIIA in a sodium channel vestibule, based on voltage dependence of its binding. Mol Pharmacol. 2011; 80(2):219-27. DOI: 10.1124/mol.111.071779. View

de Araujo A, Callaghan B, Nevin S, Daly N, Craik D, Moretta M . Total synthesis of the analgesic conotoxin MrVIB through selenocysteine-assisted folding. Angew Chem Int Ed Engl. 2011; 50(29):6527-9. DOI: 10.1002/anie.201101642. View

Stevens M, Peigneur S, Dyubankova N, Lescrinier E, Herdewijn P, Tytgat J . Design of bioactive peptides from naturally occurring μ-conotoxin structures. J Biol Chem. 2012; 287(37):31382-92. PMC: 3438967. DOI: 10.1074/jbc.M112.375733. View

Zorn S, Leipold E, Hansel A, Bulaj G, Olivera B, Terlau H . The muO-conotoxin MrVIA inhibits voltage-gated sodium channels by associating with domain-3. FEBS Lett. 2006; 580(5):1360-4. DOI: 10.1016/j.febslet.2006.01.057. View

Meadows L, Chen Y, Powell A, Clare J, Ragsdale D . Functional modulation of human brain Nav1.3 sodium channels, expressed in mammalian cells, by auxiliary beta 1, beta 2 and beta 3 subunits. Neuroscience. 2002; 114(3):745-53. DOI: 10.1016/s0306-4522(02)00242-7. View

McIntosh J, Hasson A, Spira M, Gray W, Li W, Marsh M . A new family of conotoxins that blocks voltage-gated sodium channels. J Biol Chem. 1995; 270(28):16796-802. DOI: 10.1074/jbc.270.28.16796. View

Daly N, Ekberg J, Thomas L, Adams D, Lewis R, Craik D . Structures of muO-conotoxins from Conus marmoreus. I nhibitors of tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels in mammalian sensory neurons. J Biol Chem. 2004; 279(24):25774-82. DOI: 10.1074/jbc.M313002200. View

10.

Favreau P, Benoit E, Hocking H, Carlier L, D hoedt D, Leipold E . A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors. Br J Pharmacol. 2012; 166(5):1654-68. PMC: 3419909. DOI: 10.1111/j.1476-5381.2012.01837.x. View

11.

Waxman S, Dib-Hajj S . Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med. 2005; 11(12):555-62. DOI: 10.1016/j.molmed.2005.10.004. View

12.

Dib-Hajj S, Black J, Cummins T, Kenney A, Kocsis J, Waxman S . Rescue of alpha-SNS sodium channel expression in small dorsal root ganglion neurons after axotomy by nerve growth factor in vivo. J Neurophysiol. 1998; 79(5):2668-76. DOI: 10.1152/jn.1998.79.5.2668. View

13.

Wakamatsu K, Kohda D, Hatanaka H, Lancelin J, Ishida Y, Oya M . Structure-activity relationships of mu-conotoxin GIIIA: structure determination of active and inactive sodium channel blocker peptides by NMR and simulated annealing calculations. Biochemistry. 1992; 31(50):12577-84. DOI: 10.1021/bi00165a006. View

14.

Black J, Cummins T, Plumpton C, Chen Y, Hormuzdiar W, Clare J . Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol. 1999; 82(5):2776-85. DOI: 10.1152/jn.1999.82.5.2776. View

15.

Black J, Liu S, Tanaka M, Cummins T, Waxman S . Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain. 2004; 108(3):237-247. DOI: 10.1016/j.pain.2003.12.035. View

16.

Ahn H, Black J, Zhao P, Tyrrell L, Waxman S, Dib-Hajj S . Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons. Mol Pain. 2011; 7:32. PMC: 3101130. DOI: 10.1186/1744-8069-7-32. View

17.

Decosterd I, Ji R, Abdi S, Tate S, Woolf C . The pattern of expression of the voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models. Pain. 2002; 96(3):269-277. DOI: 10.1016/S0304-3959(01)00456-0. View

18.

Gold M, Weinreich D, Kim C, Wang R, Treanor J, Porreca F . Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci. 2003; 23(1):158-66. PMC: 6742156. View

19.

Priest B, Murphy B, Lindia J, Diaz C, Abbadie C, Ritter A . Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc Natl Acad Sci U S A. 2005; 102(26):9382-7. PMC: 1166597. DOI: 10.1073/pnas.0501549102. View

20.

Pi C, Liu J, Wang L, Jiang X, Liu Y, Peng C . Soluble expression, purification and functional identification of a disulfide-rich conotoxin derived from Conus litteratus. J Biotechnol. 2006; 128(1):184-93. DOI: 10.1016/j.jbiotec.2006.09.014. View